DaVita is a major U.S. provider of kidney dialysis care, operating a large network of outpatient dialysis centers for patients with chronic kidney disease and end-stage renal disease. It delivers hemodialysis and related clinical services, often in partnership with physicians, and also manages some home dialysis programs. The business is built around recurring, clinically intensive care for a defined patient population rather than broad hospital services.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 3,379.5 | — | 199.3 | -12.7% |
| Q3 2025 | 3,420.2 | — | 150.3 | -30.8% |
| Q4 2025 | 3,619.8 | — | 234.2 | 25.7% |
| Q1 2026 | 3,415.6 | — | 197.5 | 22.7% |
| Q2 2026 | 3,554.1 | 5.2% | 265.4 | 33.1% |
All markets — KeepWinning global stock screener
Other companies on NYSE: FactSet Research Systems Inc. (FDS), Knight-Swift Transportation Holdings Inc. (KNX), Service Corporation International (SCI), TFI International Inc. (TFII), Evercore Inc. (EVR), Generac Holdings Inc. (GNRC)